| Literature DB >> 28890316 |
Neil D Telling1, James Everett2, Joanna F Collingwood3, Jon Dobson4, Gerrit van der Laan5, Joseph J Gallagher6, Jian Wang7, Adam P Hitchcock8.
Abstract
A signature characteristic of Alzheimer's disease (AD) is aggregation of amyloid-beta (Aβ) fibrils in the brain. Nevertheless, the links between Aβ and AD pathology remain incompletely understood. It has been proposed that neurotoxicity arising from aggregation of the Aβ1-42 peptide can in part be explained by metal ion binding interactions. Using advanced X-ray microscopy techniques at sub-micron resolution, we investigated relationships between iron biochemistry and AD pathology in intact cortex from an established mouse model over-producing Aβ. We found a direct correlation of amyloid plaque morphology with iron, and evidence for the formation of an iron-amyloid complex. We also show that iron biomineral deposits in the cortical tissue contain the mineral magnetite, and provide evidence that Aβ-induced chemical reduction of iron could occur in vivo. Our observations point to the specific role of iron in amyloid deposition and AD pathology, and may impact development of iron-modifying therapeutics for AD.Entities:
Keywords: Alzheimer's disease; STXM; X-ray spectromicroscopy; amyloid-beta; diffuse plaque; ferrous iron; magnetite; redox-active iron; scanning transmission X-ray microscopy; x-ray magnetic circular dichroism
Mesh:
Substances:
Year: 2017 PMID: 28890316 DOI: 10.1016/j.chembiol.2017.07.014
Source DB: PubMed Journal: Cell Chem Biol ISSN: 2451-9448 Impact factor: 8.116